Samsara BioCapital’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-689,709
| Closed | -$160K | – | 47 |
|
|
2024
Q3 | $160K | Hold |
689,709
| – | – | 0.03% | 37 |
|
|
2024
Q2 | $375K | Hold |
689,709
| – | – | 0.08% | 35 |
|
|
2024
Q1 | $704K | Hold |
689,709
| – | – | 0.11% | 34 |
|
|
2023
Q4 | $393K | Hold |
689,709
| – | – | 0.06% | 36 |
|
|
2023
Q3 | $717K | Hold |
689,709
| – | – | 0.22% | 35 |
|
|
2023
Q2 | $972K | Hold |
689,709
| – | – | 0.17% | 38 |
|
|
2023
Q1 | $1.1M | Hold |
689,709
| – | – | 0.23% | 41 |
|
|
2022
Q4 | $1.01M | Hold |
689,709
| – | – | 0.22% | 39 |
|
|
2022
Q3 | $2.95M | Hold |
689,709
| – | – | 0.69% | 30 |
|
|
2022
Q2 | $2.68M | Sell |
689,709
-21,330
| -3% | -$82.8K | 0.71% | 30 |
|
|
2022
Q1 | $3.39M | Hold |
711,039
| – | – | 0.85% | 29 |
|
|
2021
Q4 | $2.6M | Hold |
711,039
| – | – | 0.5% | 31 |
|
|
2021
Q3 | $5.7M | Hold |
711,039
| – | – | 0.89% | 24 |
|
|
2021
Q2 | $8.06M | Sell |
711,039
-120,586
| -15% | -$1.37M | 1% | 19 |
|
|
2021
Q1 | $7.69M | Buy |
+831,625
| New | +$7.69M | 1.42% | 17 |
|
|
2020
Q2 | – | Sell |
-169,663
| Closed | -$2.46M | – | 36 |
|
|
2020
Q1 | $2.46M | Hold |
169,663
| – | – | 1.42% | 19 |
|
|
2019
Q4 | $2.01M | Buy |
169,663
+66,494
| +64% | +$786K | 0.96% | 18 |
|
|
2019
Q3 | $2.6M | Buy |
103,169
+42,857
| +71% | +$1.08M | 1.77% | 12 |
|
|
2019
Q2 | $1.53M | Sell |
60,312
-46,831
| -44% | -$1.19M | 1.01% | 15 |
|
|
2019
Q1 | $4.56M | Buy |
+107,143
| New | +$4.56M | 3.58% | 9 |
|